Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism SHH inhibitors(Sonic Hedgehog Homolog inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous non-small cell lung cancer | Phase 2 | China | 17 Aug 2020 | |
Squamous non-small cell lung cancer | Phase 2 | China | 17 Aug 2020 | |
Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 May 2017 | |
Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 May 2017 |